Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.

[img]
Available under license: Creative Commons Attribution

Timpani, Cara ORCID: 0000-0003-4567-4319, Hayes, Alan ORCID: 0000-0003-1398-3694 and Rybalka, Emma ORCID: 0000-0002-4854-0036 (2017) Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy. Orphanet Journal of Rare Diseases, 12 (1). 100 - 100. ISSN 1750-1172

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/33704
DOI https://doi.org/10.1186/s13023-017-0652-y
Official URL https://ojrd.biomedcentral.com/articles/10.1186/s1...
Subjects Current > FOR Classification > 1109 Neurosciences
Current > FOR Classification > 1116 Medical Physiology
Current > Division/Research > College of Health and Biomedicine
Keywords Clinical trials; Duchenne muscular dystrophy; Neuronal nitric oxide synthase; Nitric oxide; Skeletal muscle; mdx mouse
Citations in Scopus 12 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login